Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;120:1695-1703
Published online before print October 12, 2009, doi: 10.1161/CIRCULATIONAHA.109.871137
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
120/17/1695    most recent
CIRCULATIONAHA.109.871137v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Inuzuka, Y.
Right arrow Articles by Shioi, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inuzuka, Y.
Right arrow Articles by Shioi, T.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Heart failure - basic studies
Right arrowRelated Articles

(Circulation. 2009;120:1695-1703.)
© 2009 American Heart Association, Inc.


Heart Failure

Suppression of Phosphoinositide 3-Kinase Prevents Cardiac Aging in Mice

Yasutaka Inuzuka, MD; Junji Okuda, MD; Tsuneaki Kawashima, MD; Takao Kato, MD; Shinichiro Niizuma, MD; Yodo Tamaki, MD; Yoshitaka Iwanaga, MD, PhD; Yuki Yoshida, MD, PhD; Rie Kosugi, MD, PhD; Kayo Watanabe-Maeda, MD, PhD; Yoji Machida, MD, PhD; Shingo Tsuji, PhD; Hiroyuki Aburatani, MD, PhD; Tohru Izumi, MD, PhD; Toru Kita, MD, PhD; Tetsuo Shioi, MD, PhD

From the Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto (Y. Inuzuka, J.O., T. Kawashima, T. Kato, S.N., Y.T., Y. Iwanaga, T. Kita, T.S.); Department of Cardioangiology, Kitasato University School of Medicine, Kanagawa (Y.Y., R.K., K.W.-M., Y.M., T.I.); and Genome Science Division, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo (S.T., H.A.), Japan.

Correspondence to Tetsuo Shioi, MD, PhD, Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. E-mail tshioi{at}kuhp.kyoto-u.ac.jp

Received April 8, 2009; accepted August 20, 2009.

Background— Heart failure is a typical age-associated disease. Although age-related changes of heart are likely to predispose aged people to heart failure, little is known about the molecular mechanism of cardiac aging.

Methods and Results— We analyzed age-associated changes in murine heart and the manner in which suppression of the p110{alpha} isoform of phosphoinositide 3-kinase activity modified cardiac aging. Cardiac function declined in old mice associated with the expression of senescence markers. Accumulation of ubiquitinated protein and lipofuscin, as well as comprehensive gene expression profiling, indicated that dysregulation of protein quality control was a characteristic of cardiac aging. Inhibition of phosphoinositide 3-kinase preserved cardiac function and attenuated expression of the senescence markers associated with enhanced autophagy. Suppression of target of rapamycin, a downstream effector of phosphoinositide 3-kinase, also prevented lipofuscin accumulation in the heart.

Conclusions— Suppression of phosphoinositide 3-kinase prevented many age-associated changes in the heart and preserved cardiac function of aged mice.


 

CLINICAL PERSPECTIVE


Related Articles:

Clinical Summaries
Circulation 2009 120: 1647-1648. [Extract] [Full Text]

New Insights Into Cardiac Aging
Anthony J. Muslin
Circulation 2009 120: 1654-1656. [Extract] [Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
A. J. Muslin
New Insights Into Cardiac Aging
Circulation, October 27, 2009; 120(17): 1654 - 1656.
[Full Text] [PDF]